194,095 Shares in Guardant Health Inc (GH) Acquired by Northern Trust Corp

Share on StockTwits

Northern Trust Corp purchased a new position in Guardant Health Inc (NASDAQ:GH) in the 4th quarter, Holdings Channel reports. The fund purchased 194,095 shares of the company’s stock, valued at approximately $7,296,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Citigroup Inc. purchased a new stake in Guardant Health during the fourth quarter worth about $94,000. Bank of New York Mellon Corp purchased a new stake in Guardant Health during the fourth quarter worth about $1,717,000. AGF Investments Inc. purchased a new stake in Guardant Health during the fourth quarter worth about $4,148,000. Massachusetts Financial Services Co. MA purchased a new stake in Guardant Health during the fourth quarter worth about $17,066,000. Finally, BlackRock Inc. purchased a new stake in shares of Guardant Health during the fourth quarter worth approximately $41,894,000. 69.45% of the stock is owned by institutional investors.

GH has been the topic of a number of recent research reports. William Blair restated an “outperform” rating on shares of Guardant Health in a research note on Wednesday, March 13th. JPMorgan Chase & Co. upped their target price on shares of Guardant Health from $42.00 to $85.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 13th. Zacks Investment Research lowered shares of Guardant Health from a “hold” rating to a “sell” rating in a research note on Monday, March 18th. Bank of America restated a “neutral” rating and set a $60.00 target price (up from $42.00) on shares of Guardant Health in a research note on Thursday, February 28th. Finally, Cowen upped their target price on shares of Guardant Health from $40.00 to $70.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 3rd. One analyst has rated the stock with a sell rating and five have issued a buy rating to the company. Guardant Health presently has an average rating of “Buy” and a consensus target price of $79.67.

In other Guardant Health news, major shareholder Vision Fund (Aiv M1) Softbank purchased 2,033,990 shares of the stock in a transaction that occurred on Tuesday, March 12th. The stock was purchased at an average cost of $9.83 per share, with a total value of $19,994,121.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of GH opened at $74.02 on Tuesday. Guardant Health Inc has a 52-week low of $27.04 and a 52-week high of $106.58.

Guardant Health (NASDAQ:GH) last announced its quarterly earnings results on Tuesday, March 12th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.35) by $0.05. The business had revenue of $32.87 million during the quarter, compared to analyst estimates of $24.57 million. On average, sell-side analysts predict that Guardant Health Inc will post -1.5 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “194,095 Shares in Guardant Health Inc (GH) Acquired by Northern Trust Corp” was originally posted by Macon Daily and is owned by of Macon Daily. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://macondaily.com/2019/04/16/194095-shares-in-guardant-health-inc-gh-acquired-by-northern-trust-corp.html.

Guardant Health Profile

Guardant Health, Inc, a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications.

Featured Story: FAANG Stocks

Want to see what other hedge funds are holding GH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardant Health Inc (NASDAQ:GH).

Institutional Ownership by Quarter for Guardant Health (NASDAQ:GH)

Receive News & Ratings for Guardant Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardant Health and related companies with MarketBeat.com's FREE daily email newsletter.